Serina Therapeutics Inc.

Penny Stocks Biotech Stocks Healthcare Stocks

$2.37

-0.10 (-4.05%)

As of Feb 8, 2:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +1,048.5% upside

Low Target $16.99

Average Target $27.22

High Target $37.92

Current Price $2.37

Current
$2.37

Target
$27.22

$16.99 $27.22 avg $37.92

Scenario Analysis

Bear Case

$16.99

616.9%

Low target

Base Case

$27.22

+1,048.5%

Avg target

Bull Case

$37.92

+1,500.0%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$28.44

-91.7% from high

52-Week Low

$21.76

+-89.1% from low

Target vs 52W High

$27.22

-4.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%